Drug Shortage Report for APO-OLMESARTAN

Last updated on 2020-03-30 History
Report ID 55287
Drug Identification Number 02453460
Brand name APO-OLMESARTAN
Common or Proper name OLMESARTAN MEDOXOMIL
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) OLMESARTAN MEDOXOMIL
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-09
Estimated end date 2020-06-19
Actual end date
Shortage status Actual shortage
Updated date 2020-03-30
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-03-30 French Compare
v9 2020-03-30 English Compare
v8 2019-08-16 French Compare
v7 2019-08-16 English Compare
v6 2019-04-08 French Compare
v5 2019-04-08 English Compare
v4 2018-11-30 French Compare
v3 2018-11-30 English Compare
v2 2018-07-11 French Compare
v1 2018-07-11 English Compare